Skip to main content
Clinical Trials/JPRN-UMIN000029228
JPRN-UMIN000029228
Completed
未知

Transanal or transperineal pelvic lateral lymph node dissection for lower rectal cancer and proctal cancer - Transanal or transperineal pelvic lateral lymph node dissection

Saku Central Hospital Advanced Care Center0 sites5 target enrollmentSeptember 22, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
ower Rectal Cancer and Proctal Cancer
Sponsor
Saku Central Hospital Advanced Care Center
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2017
End Date
June 13, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) The male patients with the middle or the lower rectal cancer, which are not adapted for TaTME and TpTME, which are located far from 6cm from the anal verge. Intra\-corporeal transection of the rectum and intra\-corporeal anastomosis are possible for rectal cancer. 2\) The female patients: for whom the proper surgical field is easy to obtain. There are few cases which LPLLD is hard to achieve, because the female patients usually have the wide pelvis compared to the male. 3\) When the proper surgical field or further improvement in manipulation cannot be obtained during TapPLLD, the approach method should be changed into LPLLD. 4\) The patients who are inappropriate as the subjects of this study by the corresponding doctor are excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials